Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 16  |  Issue : 5  |  Page : 561-565

Effects of Artemisia judaica essential oil and ethanolic extract on experimentally-induced benign prostatic hyperplasia


1 Department of Biological Sciences, Faculty of Science, Yarmouk University, Irbid, Jordan
2 Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Yarmouk, Jordan
3 Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan
4 Department of Chemistry, Faculty of Science, Yarmouk University, Irbid, Jordan
5 Department of Biology, Jerash University, Jerash, Jordan
6 School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, BT52 1SA, Northern Ireland, United Kingdom

Correspondence Address:
Bahaa Al-Trad
Department of Biological Sciences, Faculty of Science, Yarmouk University, Irbid 211-63
Jordan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pm.pm_216_20

Rights and Permissions

Background: Recent studies have shown that the essential oil (EO) and the ethanolic extract (EE) from Artemisia judaica L., a Jordanian medicinal plant, exhibit a potent anti-angiogenic and anti-inflammatory activities. Angiogenesis and inflammation processes are known to play a role in benign prostatic hyperplasia (BPH), a disease associated with aging in men. Objectives: The present study aimed to address the effects of EO and EE on experimentally-induced BPH in rats. Materials and Methods: Four experimental groups were assigned with six rats in each group, including the corn oil vehicle as a control. The three other groups were induced to develop BPH by testosterone injection. The BPH rats were randomized into the BPH-untreated group, BPH-EO treated group (200 mg/kg/subcutaneously) and BPH-EE treated group (500 mg/kg/orally). Results: The prostate weight/body ratio and epithelial thickness showed a significant reduction in the EO and EE treated groups compared to the BPH untreated. In addition, mRNA expression levels of the proliferating marker (proliferating cell nuclear antigen), the angiogenesis marker (vascular endothelial growth factor-A) and interleukin-6; an inflammatory cytokine, were significantly down-regulated in the BPH groups that were treated with EE or EO. Conclusion: Our results indicated that in experimentally-induced BPH, EO and EE from A. judaica ameliorate BPH development by inhibiting prostatic cell proliferation, angiogenesis, and inflammation.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed306    
    Printed2    
    Emailed0    
    PDF Downloaded34    
    Comments [Add]    

Recommend this journal